Search results for "Iodine Radioisotope"

showing 10 items of 49 documents

Cysteine-Specific Radioiodination of Proteins with Fluorescein Maleimide

1997

A protocol is described for coupling of carrier-free iodine to protein sulfhydryl groups via fluorescein maleimide. 125I is first coupled to fluorescein maleimide in the presence of chloramine T. Iodination is stopped with sodium thiosulfate, and the iodine-substituted fluorescein maleimide is reacted with free cysteines of the protein. Excess label is then removed by gel-permeation chromatography. The procedure avoids exposition of the protein to oxidative conditions and does not require purification of the labeled carrier reagent. Suitability of the method for a given protein can be evaluated spectrophotometrically without employing radioactivity. It can be applied under denaturing condit…

ErythrocytesPolymersThiosulfatesBiophysicsPlasma protein bindingSodium thiosulfateComplement Hemolytic Activity AssaySensitivity and SpecificityBiochemistryIodine RadioisotopesTosyl Compoundschemistry.chemical_compoundBacterial ProteinsCysteineFluoresceinMolecular BiologyChloramineChromatographyChloraminesProteinsHalogenationCell BiologyFluoresceinsBiochemistrychemistrySpectrophotometryReagentStreptolysinsChromatography GelStreptolysinProtein BindingCysteineAnalytical Biochemistry
researchProduct

Inhibition of ubiquitin-dependent proteolysis by a synthetic glycine-alanine repeat peptide that mimics an inhibitory viral sequence.

2002

AbstractThe glycine–alanine repeat (GAr) of the Epstein–Barr virus nuclear antigen-1 is a cis-acting transferable element that inhibits ubiquitin/proteasome-dependent proteolysis in vitro and in vivo. We have here examined the effect of a synthetic 20-mer GAr oligopeptide on the degradation of iodinated or biotin labeled lysozyme in a rabbit reticulocyte lysates in vitro assay. Micromolar concentrations of the GA-20 peptide inhibited the hydrolysis of lysozyme without significant effect on ubiquitination. Addition of the peptide did not inhibit the hydrolysis of fluorogenic substrate by purified proteasomes and did not affect the ubiquitination of lysozyme. An excess of the peptide failed t…

Herpesvirus 4 HumanProteasome Endopeptidase ComplexGly–Ala repeatPolymersProteolysisMolecular Sequence DataBiophysicsGlycineBiotinPeptideBiochemistryIodine Radioisotopeschemistry.chemical_compoundS5aUbiquitinStructural BiologyMultienzyme ComplexesGeneticsmedicineAnimalsAmino Acid SequenceEnzyme InhibitorsMolecular BiologyPeptide sequenceUbiquitinsEpstein–Barr virus nuclear antigen-1Alaninechemistry.chemical_classificationOligopeptideAlaninebiologymedicine.diagnostic_testProteasomeMolecular MimicryUbiquitinationCell BiologyCysteine EndopeptidasesBiochemistryProteasomechemistryEpstein-Barr Virus Nuclear AntigensIsotope Labelingbiology.proteinMuramidaseRabbitsLysozymeCarrier ProteinsPeptidesOligopeptidesFEBS letters
researchProduct

Detection of IgA and IgM antibodies to HIV-1 in neonates by radioimmune western blotting.

1992

OBJECTIVE--To detect infection with HIV-1 by IgA and IgM response at birth in children born to HIV-1 seropositive mothers. DESIGN--Western blotting and radioimmune western blotting on stored sera from infected and uninfected babies born to HIV-1 seropositive mothers. Sera were pretreated to remove IgG. SETTING--Parma and Bologna, Italy. SUBJECTS--12 infected and five uninfected babies born to HIV-1 seropositive mothers and three babies born to seronegative mothers. MAIN OUTCOME MEASURES--Effectiveness of western blotting and radioimmune western blotting in detecting antibodies to HIV-1 gene products. RESULTS--With conventional western blotting we found IgA class antibodies to HIV-1 proteins…

Immunoglobulin ALetterIgm antibodyBlotting WesternHuman immunodeficiency virus (HIV)HIV InfectionsHIV Antibodiesmedicine.disease_causeSerologyIodine RadioisotopesPregnancyImmunopathologyHIV SeropositivitymedicineHumansPregnancy Complications InfectiousMaternal-Fetal ExchangeGeneral Environmental SciencePregnancybiologybusiness.industryGeneral EngineeringInfant NewbornObstetrics and GynecologyInfantGeneral Medicinemedicine.diseaseVirologyImmunoglobulin ABlotImmunoglobulin MImmunoglobulin MImmunologybiology.proteinHIV-1General Earth and Planetary SciencesFemaleViral diseaseAntibodybusinessResearch ArticleBMJ (Clinical research ed.)
researchProduct

Screening for Bacillus thuringiensis Crystal Proteins Active against the Cabbage Looper, Trichoplusia ni

2000

Abstract Toxicity tests were performed to find among Cry1 and Cry2 Bacillus thuringiensis crystal proteins those with high activity against the cabbage looper. Tests were performed with neonate larvae on surface-contaminated artificial diet. The crystal proteins found to be toxic were, from higher to lower toxicity: Cry1Ac, Cry1Ab, Cry1C, Cry2Aa, Cry1J, and Cry1F (LC50 of 1.1–4.1, 3.4–4.4, 12, 34, 87, and 250 ng/cm2, respectively). Cry1B, Cry1D, and Cry1E can be considered nontoxic (LC50 higher than 2500 ng/cm2). Cry1Aa was moderately toxic to nontoxic, depending on the source (LC50 of 420 ng/cm2 from PGS and 8100 ng/cm2 from Ecogen). In vitro binding assays with trypsin-activated 125I-labe…

InsecticidesBacillus thuringiensis ToxinsBrush borderBacterial ToxinsfungiBacillus thuringiensisMidgutMothsBiologybiology.organism_classificationBacillalesEndotoxinsIodine RadioisotopesHemolysin ProteinsBacterial ProteinsCry1AcBiochemistryCabbage looperBacillus thuringiensisBotanyToxicityTrichoplusiaAnimalsPest Control BiologicalEcology Evolution Behavior and SystematicsJournal of Invertebrate Pathology
researchProduct

Mapping of the high molecular weight kininogen binding site of prekallikrein. Evidence for a discontinuous epitope formed by distinct segments of the…

1993

Prekallikrein, a glycoprotein involved in contact phase activation, circulates in plasma in the form of a binary complex with high molecular weight kininogen (H-kininogen). The binding to H-kininogen is mediated by the prekallikrein heavy chain consisting of four repetitive domains, A1-A4. To define more precisely the region(s) involved in kininogen binding, we have employed an affinity cross-linking strategy with a synthetic peptide of 31 residues which mimics the prekallikrein binding site of H-kininogen. Cross-linking of the radiolabeled peptide to (pre)kallikrein revealed a binding segment in the NH2-terminal portion of the prekallikrein heavy chain; another binding segment was located …

Kininogen bindingHigh-molecular-weight kininogenMacromolecular SubstancesMolecular Sequence DataEnzyme-Linked Immunosorbent AssayBiochemistryBinding CompetitiveIodine RadioisotopesHigh molecular weight kininogen bindingEpitopesZymogenHumansAmino Acid SequenceBinding siteMolecular BiologyKininogenBinding SitesChemistryKininogensPrekallikreinPrekallikreinCell BiologyKallikreinPeptide FragmentsModels StructuralMolecular WeightKineticsBiochemistryAutoradiographyElectrophoresis Polyacrylamide GelPeptidescirculatory and respiratory physiology
researchProduct

Pleural epithelioid angiosarcoma with lymphatic differentiation arisen after radiometabolic therapy for thyroid carcinoma: immunohistochemical findin…

2017

Abstract Background Pleural angiosarcoma is a rare tumor that causes diffuse pleural thickening and effusion, mimicking mesothelioma. Immunohistochemistry is needed to highlight endothelial differentiation. We describe the first case of pleural angiosarcoma with lymphatic differentiation following radiometabolic therapy for thyroid carcinoma. Case presentation A 50-year-old man showed diffuse pleural thickening and effusion. Nine years earlier, he underwent thyroidectomy and radiometabolic therapy for thyroid carcinoma with lymph node metastases. Histologically, the tumor consisted of a solid proliferation of atypical epithelioid cells and anastomosed vascular spaces, lacking of red blood c…

Male0301 basic medicinePathologymedicine.medical_specialtyNeoplasms Radiation-InducedHistologyPleural NeoplasmsHemangiosarcomaReviewRadiometabolic therapyPathology and Forensic MedicineIodine RadioisotopeIodine RadioisotopesThyroid carcinoma03 medical and health sciences0302 clinical medicinelcsh:PathologymedicineHumansAngiosarcomaThyroid NeoplasmsMesotheliomaPleural NeoplasmPleural angiosarcomaPleural NeoplasmLymph nodebusiness.industryThyroid CarcinomaGeneral MedicineMiddle Agedmedicine.diseaseImmunohistochemistryCarcinoma Papillary030104 developmental biologymedicine.anatomical_structureHemangiosarcomaLymphatic systemThyroid Cancer Papillary030220 oncology & carcinogenesisbusinessEpithelioid celllcsh:RB1-214HumanDiagnostic Pathology
researchProduct

Inferring postimplant dose distribution of salvage permanent prostate implant (PPI) after primary PPI on CT images

2018

International audience; PURPOSE:To evaluate the dose distribution of additional radioactive seeds implanted during salvage permanent prostate implant (sPPI) after a primary permanent prostate implant (pPPI).METHODS AND MATERIALS:Patients with localized prostate cancer were primarily implanted with iodine-125 seeds and had a dosimetric assessment based on day 30 postimplant CT (CT1). After an average of 6 years, these patients underwent sPPI followed by the same CT-based evaluation of dosimetry (CT2). Radioactive seeds on each CT were detected. The detected primary seeds on CT1 and CT2 were registered and then removed from CT2 referred as a modified CT2 (mCT2). Dosimetry evaluations (D90 and…

MaleBrachytherapy[SDV.CAN]Life Sciences [q-bio]/CancerDose distribution[SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology030218 nuclear medicine & medical imagingIodine Radioisotopes03 medical and health sciencesProstate cancer0302 clinical medicineProstateDosimetryIodine seedsmedicineHumansDosimetryRadiology Nuclear Medicine and imagingRadiometrySalvage TherapyPrimary permanentSalvage brachytherapyProstate cancerbusiness.industryProstateProstatic NeoplasmsProstate implantRadiotherapy Dosagemedicine.disease3. Good healthmedicine.anatomical_structureOncology030220 oncology & carcinogenesisTomography X-Ray ComputedbusinessNuclear medicineSalvage brachytherapy[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Biochemical properties of MHC class II molecules endogenously synthesized and expressed by mouse Langerhans cells

1991

The cell surface expression and biosynthesis of Langerhans cells (LC)-derived major histocompatibility complex (MHC) class II molecules from epidermal cells (EC) prepared freshly and cultured for up to 3 days was investigated. Based on the constitutive expression of MHC class II determinants by LC, a panning and magnetic bead selection procedure was employed, yielding 65% and 86% of I-A+ cells, respectively. Phenotypical and cytochemical examinations revealed that the two LC preparations were free of contaminating macrophages as well as B and T cells. Freshly prepared enriched LC were highly efficient in the stimulation of protein antigen-specific T cell clones, while LC purified from short…

MaleLangerhans cellT cellImmunologyCellMajor histocompatibility complexFlow cytometryIodine RadioisotopesMicemedicineAnimalsImmunology and AllergyCells CulturedLymphokinesMice Inbred BALB CMice Inbred C3HMHC class IIEpidermis (botany)medicine.diagnostic_testbiologyHistocompatibility Antigens Class IIFlow CytometryMolecular biologyIn vitroPhenotypemedicine.anatomical_structureLangerhans CellsImmunologybiology.proteinFemaleEuropean Journal of Immunology
researchProduct

Intraoperative localization of malignant pheochromocytoma by 123-i-metaiodobenzylguanidine single probe measurement

1988

Metaiodobenzylguanidine (MIBG) imaging is a well-established method for locating intra- and extraadrenal pheochromocytomas. We investigated whether preoperative injection of 123-I-MIBG might be useful for intraoperative staging of chromaffine tumor cells. This was performed in a 46-year-old patient in whom the diagnosis of a malignant pheochromocytoma had been established by 123-I-MIBG imaging and enhanced catecholamine secretion. The rationale for intraoperative staging in this patient was a discrepancy between computed tomography (CI) of the abdomen and the radionuclide imaging, because scintigraphy revealed a mass with MIBG uptake in the right lower abdomen that could not be visualized b…

MaleMalignant Pheochromocytomamedicine.medical_specialtyAdrenal Gland NeoplasmAdrenal Gland NeoplasmsPheochromocytomaScintigraphy3-IodobenzylguanidineIodine RadioisotopesPheochromocytomaDrug DiscoverymedicineHumansSingle probeNeoplasm MetastasisRadionuclide ImagingGenetics (clinical)medicine.diagnostic_testIodobenzenesbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseAbdominal mass3-Iodobenzylguanidinemedicine.anatomical_structureMolecular MedicineAbdomenRadiologymedicine.symptomNuclear medicinebusinessKlinische Wochenschrift
researchProduct

Focal or whole-gland salvage prostate brachytherapy with iodine seeds with or without a rectal spacer for postradiotherapy local failure: How best to…

2016

International audience; PURPOSE: Salvage prostate permanent implant (sPPI) for postradiation local failure provides high rates of biochemical control. The cumulative dose delivered to the prostate and the rectum is still unknown. METHODS AND MATERIALS: We reviewed the postimplant CT-based dosimetry of 18 selected patients who underwent sPPI with I-125 seeds for isolated biopsy-proven local failure several years after external beam radiation therapy. Ten patients had whole-prostate sPPI, and 8 patients had multiparametric MRI-based focal sPPI. In 8 patients, hyaluronic acid (HA) gel was injected into the prostate rectum space. RESULTS: The median cumulative biological effective dose after EB…

MaleOrgans at Risk[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imagingmedicine.medical_treatmentBrachytherapySalvage therapyRecommendationsAlpha/Beta030218 nuclear medicine & medical imaging[ SDV.CAN ] Life Sciences [q-bio]/Cancer[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicineIodine RadioisotopesBiologically effective doseProstate cancer0302 clinical medicineProstatePositron Emission Tomography Computed Tomography[ SDV.IB ] Life Sciences [q-bio]/BioengineeringHyaluronic Acid[ SDV.IB.IMA ] Life Sciences [q-bio]/Bioengineering/ImagingProstate cancerCumulative doseCancer RecurrencesRadiotherapy DosageMenLow dose rateMiddle AgedImplantation3. Good healthmedicine.anatomical_structureOncology030220 oncology & carcinogenesis[SDV.IB]Life Sciences [q-bio]/BioengineeringLocal failureProstate brachytherapymedicine.medical_specialtyBrachytherapyRectum[SDV.CAN]Life Sciences [q-bio]/Cancer[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicineRadiation Dosage03 medical and health sciencesPermanent BrachytherapymedicineHumansProctitisRadiology Nuclear Medicine and imagingRadiation InjuriesProctitisAgedSalvage TherapySalvage brachytherapyRadiotherapybusiness.industryRadiotherapy Planning Computer-AssistedCarcinomaRectumProstatic Neoplasmsmedicine.diseaseRadiation-TherapySurgeryNeoplasm Recurrence LocalTomography X-Ray ComputedNuclear medicinebusinessGels
researchProduct